98 related articles for article (PubMed ID: 25142087)
21. Effects of miglitol, sitagliptin, and initial combination therapy with both on plasma incretin responses to a mixed meal and visceral fat in over-weight Japanese patients with type 2 diabetes. "the MASTER randomized, controlled trial".
Mikada A; Narita T; Yokoyama H; Yamashita R; Horikawa Y; Tsukiyama K; Yamada Y
Diabetes Res Clin Pract; 2014 Dec; 106(3):538-47. PubMed ID: 25451890
[TBL] [Abstract][Full Text] [Related]
22. Glucose-responsive Insulinoma with Insulin Hypersecretion Suppressed by Metformin.
Hamano K; Akita K; Takeuchi Y; Suwa T; Takeda J; Dodo S
Intern Med; 2019 Dec; 58(24):3563-3568. PubMed ID: 31462593
[TBL] [Abstract][Full Text] [Related]
23. Effect of insulin-unstimulated diabetic therapy with miglitol on serum cystatin C level and its clinical significance.
Yokoyama H; Inoue T; Node K
Diabetes Res Clin Pract; 2009 Jan; 83(1):77-82. PubMed ID: 19027977
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol.
Uzu T; Yokoyama H; Itoh H; Koya D; Nakagawa A; Nishizawa M; Maegawa H; Yokomaku Y; Araki S; Abiko A; Haneda M
Clin Exp Nephrol; 2011 Feb; 15(1):58-63. PubMed ID: 20824296
[TBL] [Abstract][Full Text] [Related]
25. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
[TBL] [Abstract][Full Text] [Related]
26. Comparing the efficacy of α-glucosidase inhibitors in suppressing postprandial hyperglycemia using continuous glucose monitoring: a pilot study-the MAJOR study.
Tsujino D; Nishimura R; Taki K; Morimoto A; Tajima N; Utsunomiya K
Diabetes Technol Ther; 2011 Mar; 13(3):303-8. PubMed ID: 21291335
[TBL] [Abstract][Full Text] [Related]
27. Single administration of alpha-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease - Juntendo University trial: effects of miglitol on endothelial vascular reactivity in type 2 diabetic patients with coronary heart disease (J-MACH) -.
Hiki M; Shimada K; Kiyanagi T; Fukao K; Hirose K; Ohsaka H; Fukushima Y; Kume A; Matsumori R; Sumiyoshi K; Miyazaki T; Ohmura H; Kurata T; Miida T; Daida H
Circ J; 2010 Jul; 74(7):1471-8. PubMed ID: 20519875
[TBL] [Abstract][Full Text] [Related]
28. α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study.
Shimabukuro M; Tanaka A; Sata M; Dai K; Shibata Y; Inoue Y; Ikenaga H; Kishimoto S; Ogasawara K; Takashima A; Niki T; Arasaki O; Oshiro K; Mori Y; Ishihara M; Node K;
Cardiovasc Diabetol; 2017 Jul; 16(1):86. PubMed ID: 28683829
[TBL] [Abstract][Full Text] [Related]
29. Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients.
Schnack C; Prager RJ; Winkler J; Klauser RM; Schneider BG; Schernthaner G
Diabetes Care; 1989 Sep; 12(8):537-43. PubMed ID: 2673693
[TBL] [Abstract][Full Text] [Related]
30. Meal composition is a determinant of lispro-induced hypoglycemia in IDDM.
Burge MR; Castillo KR; Schade DS
Diabetes Care; 1997 Feb; 20(2):152-5. PubMed ID: 9118763
[TBL] [Abstract][Full Text] [Related]
31. A Journey to Improved Inpatient Glycemic Control by Redesigning Meal Delivery and Insulin Administration.
Engle M; Ferguson A; Fields W
Clin Nurse Spec; 2016; 30(2):117-24. PubMed ID: 26848903
[TBL] [Abstract][Full Text] [Related]
32. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet.
Kellogg TA; Bantle JP; Leslie DB; Redmond JB; Slusarek B; Swan T; Buchwald H; Ikramuddin S
Surg Obes Relat Dis; 2008; 4(4):492-9. PubMed ID: 18656831
[TBL] [Abstract][Full Text] [Related]
33. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy.
Miholic J; Orskov C; Holst JJ; Kotzerke J; Meyer HJ
Dig Dis Sci; 1991 Oct; 36(10):1361-70. PubMed ID: 1914756
[TBL] [Abstract][Full Text] [Related]
34. Miglitol improves postprandial endothelial dysfunction in patients with acute coronary syndrome and new-onset postprandial hyperglycemia.
Kitano D; Chiku M; Li Y; Okumura Y; Fukamachi D; Takayama T; Hiro T; Saito S; Hirayama A
Cardiovasc Diabetol; 2013 Jun; 12():92. PubMed ID: 23777506
[TBL] [Abstract][Full Text] [Related]
35. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of α-glucosidase inhibitors on postprandial plasma glucose and lipid profile in patients with type 2 diabetes under control with insulin lispro mix 50/50.
Kimura T; Suzuki J; Ichikawa M; Imagawa M; Sato S; Fujii M; Zenimaru Y; Inaba S; Takahashi S; Konoshita T; Miyamori I
Diabetes Technol Ther; 2012 Jul; 14(7):545-51. PubMed ID: 22519736
[TBL] [Abstract][Full Text] [Related]
37. Pioglitazone prevents reactive hypoglycemia in impaired glucose tolerance.
Arii K; Ota K; Suehiro T; Ikeda Y; Nishimura K; Kumon Y; Hashimoto K
Diabetes Res Clin Pract; 2005 Sep; 69(3):305-8. PubMed ID: 16098929
[TBL] [Abstract][Full Text] [Related]
38. Design and evaluation of oral bioadhesive controlled release formulations of miglitol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels.
Deshpande MC; Venkateswarlu V; Babu RK; Trivedi RK
Int J Pharm; 2009 Oct; 380(1-2):16-24. PubMed ID: 19563873
[TBL] [Abstract][Full Text] [Related]
39. The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus.
Osonoi T; Saito M; Mochizuki K; Fukaya N; Muramatsu T; Inoue S; Fuchigami M; Goda T
Metabolism; 2010 Dec; 59(12):1816-22. PubMed ID: 20667563
[TBL] [Abstract][Full Text] [Related]
40. Automatic Detection and Estimation of Unannounced Meals for Multivariable Artificial Pancreas System.
Samadi S; Rashid M; Turksoy K; Feng J; Hajizadeh I; Hobbs N; Lazaro C; Sevil M; Littlejohn E; Cinar A
Diabetes Technol Ther; 2018 Mar; 20(3):235-246. PubMed ID: 29406789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
